Position in HLN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,203,582
+$58,847 QoQ
Shares Held
120,238
+6.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 72%
Shared 13%
None 14%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Savant Capital, LLC holds $7,637,562 across 13 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,326 | $1,379,271 | |
| 2 | HLN |
Haleon plc
This page
|
120,238 | $1,203,582 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
16,004 | $770,592 | |
| 4 | VTRS |
Viatris Inc
|
53,146 | $718,002 | |
| 5 | ZTS |
Zoetis Inc.
|
5,226 | $617,765 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,960 | $603,766 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
27,454 | $508,448 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
36,445 | $504,763 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,203,582 | 120,238 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,144,735 | 113,228 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $247,410 | 27,582 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $798,127 | 76,965 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $309,296 | 30,058 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $251,789 | 26,393 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $140,195 | 13,251 | Shares | Sole | 2024-11-04 | |
| 2023-09-30 | $123,317 | 14,804 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $96,990 | 11,574 | Shares | Sole | 2023-08-04 | |
| No filing history on record for this holder in this stock. | ||||||